Ctt Pharmaceutical Holdings Stock Analysis
CTTH Stock | USD 0.03 0 7.48% |
CTT Pharmaceutical Holdings is fairly valued with Real Value of 0.034 and Hype Value of 0.03. The main objective of CTT Pharmaceutical pink sheet analysis is to determine its intrinsic value, which is an estimate of what CTT Pharmaceutical Holdings is worth, separate from its market price. There are two main types of CTT Pharmaceutical's stock analysis: fundamental analysis and technical analysis.
The CTT Pharmaceutical pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and CTT Pharmaceutical's ongoing operational relationships across important fundamental and technical indicators.
CTT |
CTT Pink Sheet Analysis Notes
The company recorded a loss per share of 0.08. CTT Pharmaceutical had not issued any dividends in recent years. The entity had 1:10 split on the 28th of August 2015. CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. The company was formerly known as Mindesta Inc. and changed its name to CTT Pharmaceutical Holdings, Inc. in July 2015. Ctt Pharmaceutical is traded on OTC Exchange in the United States.The quote for CTT Pharmaceutical Holdings is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on CTT Pharmaceutical Holdings please contact the company at 613-241-9959 or go to https://www.cttpharmaceuticals.com.CTT Pharmaceutical Investment Alerts
CTT Pharmaceutical is way too risky over 90 days horizon | |
CTT Pharmaceutical has some characteristics of a very speculative penny stock | |
CTT Pharmaceutical appears to be risky and price may revert if volatility continues | |
CTT Pharmaceutical has high likelihood to experience some financial distress in the next 2 years | |
The company reported the previous year's revenue of 40 K. Net Loss for the year was (1.38 M) with profit before overhead, payroll, taxes, and interest of 0. | |
CTT Pharmaceutical Holdings currently holds about 32.12 K in cash with (145.16 K) of positive cash flow from operations. |
CTT Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 16.17 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate CTT Pharmaceutical's market, we take the total number of its shares issued and multiply it by CTT Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 23rd of July, CTT Pharmaceutical shows the mean deviation of 10.85, and Risk Adjusted Performance of 0.0305. CTT Pharmaceutical technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.CTT Pharmaceutical Price Movement Analysis
The output start index for this execution was thirty-two with a total number of output elements of twenty-nine. The MESA Adaptive Moving Average indicator adapts to CTT Pharmaceutical price movement based on the rate change of phase as measured by the Hilbert Transform Discriminator.
CTT Pharmaceutical Outstanding Bonds
CTT Pharmaceutical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. CTT Pharmaceutical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most CTT bonds can be classified according to their maturity, which is the date when CTT Pharmaceutical Holdings has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
MPLX LP 4125 Corp BondUS55336VAK61 | View | |
US12657NAA81 Corp BondUS12657NAA81 | View | |
US12653CAJ71 Corp BondUS12653CAJ71 | View | |
CNX 7375 15 JAN 31 Corp BondUS12653CAK45 | View | |
BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
US12654AAA97 Corp BondUS12654AAA97 | View | |
Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
Valero Energy Partners Corp BondUS91914JAA07 | View |
CTT Pharmaceutical Predictive Daily Indicators
CTT Pharmaceutical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of CTT Pharmaceutical pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
CTT Pharmaceutical Forecast Models
CTT Pharmaceutical's time-series forecasting models are one of many CTT Pharmaceutical's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary CTT Pharmaceutical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About CTT Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how CTT Pharmaceutical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling CTT shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as CTT Pharmaceutical. By using and applying CTT Pink Sheet analysis, traders can create a robust methodology for identifying CTT entry and exit points for their positions.
CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. The company was formerly known as Mindesta Inc. and changed its name to CTT Pharmaceutical Holdings, Inc. in July 2015. Ctt Pharmaceutical is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding CTT Pharmaceutical to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Analyzer Now
Portfolio AnalyzerPortfolio analysis module that provides access to portfolio diagnostics and optimization engine |
All Next | Launch Module |
Complementary Tools for CTT Pink Sheet analysis
When running CTT Pharmaceutical's price analysis, check to measure CTT Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CTT Pharmaceutical is operating at the current time. Most of CTT Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of CTT Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CTT Pharmaceutical's price. Additionally, you may evaluate how the addition of CTT Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |